Resmed (RMD) Consolidated Net Income (2009 - 2026)

Resmed has reported Consolidated Net Income for 18 years, with the latest figure at $398.7 million in Q1 2026.

• For the quarter ending Q1 2026, Consolidated Net Income rose 9.23% year-over-year to $398.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (up 15.71% YoY), and the FY2025 full-year result was $1.4 billion, up 37.2% from the prior year.
• Consolidated Net Income for Q1 2026 stood at $398.7 million, up from $392.6 million in the prior quarter.
• The five-year high for Consolidated Net Income was $398.7 million in Q1 2026, with the low at $179.0 million in Q1 2022.
• Historically, Consolidated Net Income has averaged $284.3 million across 5 years, with a median of $292.2 million in 2024.
• Annual changes were most pronounced in 2022 — Consolidated Net Income jumped 328.1% — and 2023, when it slipped 7.16%.
• Resmed's Consolidated Net Income stood at $224.9 million in 2022, then dropped by 7.16% to $208.8 million in 2023, then soared by 65.05% to $344.6 million in 2024, then increased by 13.92% to $392.6 million in 2025, then advanced by 1.56% to $398.7 million in 2026.
• The last three Consolidated Net Income figures came in at $398.7 million (Q1 2026), $392.6 million (Q4 2025), and $348.5 million (Q3 2025), per Business Quant data.